Behrens, Carmen <br/><br/>
EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2013 
 - 6556-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-3946  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--enzymology<br/>Aged<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Non-Small-Cell Lung--enzymology<br/>Carcinoma, Squamous Cell--enzymology<br/>DNA-Binding Proteins--metabolism<br/>Disease Progression<br/>Enhancer of Zeste Homolog 2 Protein<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung--enzymology<br/>Lung Neoplasms--enzymology<br/>Male<br/>Multivariate Analysis<br/>Polycomb Repressive Complex 2--metabolism<br/>Prognosis<br/>Proportional Hazards Models<br/>ROC Curve<br/>Transcription Factors<br/>Treatment Outcome